Related Experiment Video
Updated: May 17, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Type 2 diabetes in children: a growing epidemic
Erin L St Onge1, Carol A Motycka, Renee L Rose
1University of Florida College of Pharmacy, Gainesville, Florida.
Insights
Type 2 diabetes in children is rising, linked to obesity and inactivity. Lifestyle changes are key, but medication may be needed, with healthcare providers guiding treatment decisions.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Public Health
Background:
- Type 2 diabetes is a growing concern in children, often linked to obesity and sedentary lifestyles.
- Untreated diabetes and obesity can lead to serious health complications like cardiovascular disease, nephropathy, and retinopathy.
- The healthcare system faces significant strain due to the rising prevalence of pediatric obesity and diabetes.
Purpose of the Study:
- To review the correlation between pediatric type 2 diabetes, obesity, and lifestyle factors.
- To discuss the role of lifestyle modifications and pharmacological interventions in managing pediatric diabetes.
- To highlight the importance of healthcare practitioner education for informed patient decision-making.
Main Methods:
- Literature review on pediatric type 2 diabetes, obesity, and treatment options.
- Analysis of existing studies on the safety and efficacy of weight management and diabetes medications in children.
- Synthesis of information regarding the impact of lifestyle and pharmacological therapies.
Main Results:
- Lifestyle changes (exercise, healthy eating) are recommended but not always sufficient for blood sugar control.
- Orlistat and sibutramine show promise for obesity treatment in pediatric populations.
- Metformin and insulin are approved diabetes medications for children and adolescents.
Conclusions:
- Healthcare providers must educate families on obesity-related diseases and treatment options.
- Informed decisions about medication benefits and risks are crucial for managing pediatric diabetes.
- Integrated approaches involving lifestyle changes and appropriate pharmacological treatments are essential.
Abstract:
In the pediatric population, type 2 diabetes has become a growing concern. A correlation appears to exist among type 2 diabetes in children, obesity, and a sedentary lifestyle. If obesity and diabetes are left untreated, conditions such as cardiovascular disease, nephropathy, and retinopathy may result as well. These conditions indicate the incredible strain on the health care system caused by diabetes and obesity. This strain may be eased by logical treatments such as exercise and healthy eating habits for the child and family. However, these lifestyle changes are not always effective in controlling blood sugar. When lifestyle changes do not yield positive results, the clinician must decide which (if any) pharmacological treatments are safe to use in the pediatric population. Orlistat and sibutramine have been studied in children as treatments for obesity and appear to be safe and effective for this population. Metformin and insulin are among the medications approved to treat diabetes in children and adolescents. Healthcare practitioners must play a role in educating parents and their children about the effects of obesity on the development of diseases like diabetes, as well as various therapies used to manage diabetes. In addition, healthcare practitioners can assist patients and their parents in understanding the benefits and risks of medications used in the treatment of the disease, assistance that may result in them making informed decisions regarding their overall health.
Related Concept Videos
Type II Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology
